Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03030573
Other study ID # Beaujon Hospital
Secondary ID
Status Recruiting
Phase N/A
First received November 19, 2016
Last updated February 5, 2017
Start date November 2015
Est. completion date November 2018

Study information

Verified date February 2017
Source Beaujon Hospital
Contact Safi Dokmak, MD
Phone 0033140875797
Email safi.dokmak@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators developed a new surgical technique in order to reconstruct the bile duct with the round ligament


Description:

Classically, the bile duct defect after bile duct injury or resection is achieved by bilioenteric reconstruction. However bilioenteric anastomosis is associated with long term complications including intrahepatic bile ducts infection, specific complications related to the Roux en Y jejunal loop and eliminate the endoscopic access to intrahepatic bile ducts. The investigators had recently developed a new surgical technique to reconstruct the veins with the parietal peritoneum with excellent results. Accordingly the investigators decided to develop a new surgical technique in order to reconstruct the bile duct defects with the vascularized round ligament.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date November 2018
Est. primary completion date November 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

1. Radiological or operative diagnosis of bile duct Injury or defect

2. Can underwent surgical procedure

Exclusion Criteria:

1) The absence of the round ligament

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Reconstruction of the bile duct with the round ligament
In patients who had bile duct defect by injury or resection, the Round ligament will be used to reconstruct the defect. Surgical technique, the early and long term postoperative measures are detailed in the investigators protocol.

Locations

Country Name City State
France Departement HPB surgery, Beaujon Hospital Clichy Hauts de seine

Sponsors (1)

Lead Sponsor Collaborator
Beaujon Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety - absence of any severe complication or mortality related to the new procedure Safety is defined by the absence of any severe complication (necrosis or biliary fistula) or mortality related to the new procedure. at 1 year
Secondary Bile buct patency Secondary outcome include mainly the patency of the reconstructed bile duct. at 3 year
See also
  Status Clinical Trial Phase
Completed NCT03708445 - Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer N/A
Enrolling by invitation NCT03951324 - Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
Recruiting NCT03821025 - Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction N/A
Recruiting NCT04759794 - Clinical Validation of an Immunocytochemistry Method Using MARS1 N/A
Recruiting NCT03546049 - Ultrasound-guided Percutaneous Biliary Drainage Versus Endoscopic Ultrasound-guided Biliary Drainage N/A
Completed NCT03541590 - Ultrasound-guided Percutaneous Biliary Drainage With Primary Metal Implantation by Endoscopic Luminal Guidance